DIMENSION® CLINICAL CHEMISTRY SYSTEM
Report
- Report Number
- 2517506-2015-00179
- Event Type
- Malfunction
- Date Received
- September 8, 2015
- Date of Event
- July 24, 2015
- Report Date
- August 10, 2015
- Manufacturer
- SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
- Product Code
- CGX
- PMA / PMN Number
- K132638
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS, US
- Reporter Occupation
- MEDICAL TECHNOLOGIST
Narratives
ANALYSIS OF THE INSTRUMENT AND INSTRUMENT DATA INDICATE THAT THE CAUSE FOR THE DISCORDANT CREATININE (CR2) ELEVATED RESULTS RELATIVE TO RECOVERIES BY AN ALTERNATE METHODOLOGY IS UNKNOWN. THE ACCOUNT SITE SWITCHED PATIENT TESTING FOR CREATININE TO THE ENZYMATIC CREATININE METHOD. THE ISSUE IS UNDER INVESTIGATION BY SIEMENS HEALTHCARE DIAGNOSTICS INC.
AN ACCOUNT COMPLAINED OF DISCORDANT CREATININE (CRE2) ELEVATED RESULTS RELATIVE TO RECOVERIES BY AN ALTERNATE METHODOLOGY. THE ACCOUNT HAS NOTED ELEVATED CRE2 RESULT SINCE PLACING THE REAGENT INTO USE ON THE DIMENSION EXL 200 IN (B)(6) 2015. PATIENT RESULTS WERE REPORTED TO PHYSICIANS. THE ACCOUNT REPEATED THE SAMPLES WITH AN ALTERNATE DIMENSION REAGENT (ENZYMATIC CREATININE -EZCR) LOWER RESULTS WERE OBTAINED IN ALIGNMENT WITH PHYSICIAN EXPECTATIONS. PATIENT TREATMENT WAS ALTERED ON THE BASIS OF THE DISCORDANT ELEVATED CRE2 RESULT. PATIENT CHEMOTHERAPY TREATMENTS WERE WITHHELD DUE TO THE SHIFT IN CRE2 VALUES AS COMPARED TO SERUM CREATININE VALUES OBTAINED PRIOR TO USING THE EXL 200. PATIENTS SCHEDULED FOR CT SCANS WERE UNABLE TO RECEIVE CONTRAST MEDIA DUE TO THE SHIFT IN SERUM CREATININE. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE DISCORDANT ELEVATED CRE2 RESULTS OR ALTERATIONS IN TREATMENTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 593366 | DIMENSION® CLINICAL CHEMISTRY SYSTEM | CREATININE FLEX® REAGENT CARTRIDGE | CGX | SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW | FA6093 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |